Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Supports Digital Pathology Across the Globe Through Sponsorship of Three Societies
As a new partner of the Asian Society of Digital Pathology, Leica Biosystems now supports all three continental digital pathology societies.
Leica Biosystems Opens New Center of Innovation to Transform Precision Medicine Development
Leica Biosystems’ new R&D facility will serve as a hub for collaborative research with leading pharmaceutical and academic institutions.
Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays
Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care.
Leica Biosystems at a Glance
150+ Years of Innovation
|
2012 - Present |
New Era of Science & Technology |
|
2005 - 2011 |
Global Expansion Accelerates |
|
1989 - 2004 |
Structuring for Comprehensive Workflow |
|
1930 - 1988 |
Novel Products Drive Company Growth |
|
1900 - 1930 |
Microtomy Technology Advances Amidst Wartime Realities |
|
1872 - 1899 |
The Creation of the Microtome and the Early Years of R. Jung GMBH |
<
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.